Dynamic changes in the gut microbiota composition during adalimumab therapy in patients with ulcerative colitis: implications for treatment response prediction and therapeutic targets
The gut microbiota undergoes diverse changes according to the treatment response during ADA treatment. These changes provide insights into predicting treatment responses to ADA and offer new therapeutic targets for UC.
Authors
- Hyung‐Kyoon Choi (ORCID: https://orcid.org/0000-0002-4523-0534)
- Seung Yong Shin (ORCID: https://orcid.org/0000-0002-3408-6899)
- Kang‐Moon Lee (ORCID: https://orcid.org/0000-0003-2850-4553)
- Wonyong Kim (ORCID: https://orcid.org/0000-0001-9649-3919)
- Hyo Jong Kim
- Han Na Oh
- Chang‐Hwan Choi (ORCID: https://orcid.org/0000-0003-2715-7393)
- Woo Jun Sul (ORCID: https://orcid.org/0000-0002-7016-1454)
- Seok‐Young Kim (ORCID: https://orcid.org/0000-0001-8566-839X)
- Jong-Hwa Kim (ORCID: https://orcid.org/0000-0002-9300-6465)
- Jihye Baek
- Soo Jung Park
Institutions
- Yonsei University (KR)
- Kyung Hee University (KR)
- The Catholic University of Korea St. Vincent's Hospital (KR)
- Ajou University (KR)
- Chung-Ang University (KR)
Publication Details
- Journal
- Gut Pathogens
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1186/s13099-024-00637-5
- Citations
- 3
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.70
Funders
- National Research Foundation
- Chung-Ang University
- National Research Foundation of Korea